Tags: Chemical Compound, Chemical Substance.

Daclatasvir (USAN) (formerly BMS-790052) is an experimental drug candidate for the treatment of hepatitis C (HCV). It is being developed by Bristol-Myers Squibb.Daclatasvir inhibits the HCV nonstructural protein NS5A.

Daclatasvir.svg
IUPAC name
Methyl [(2S)-1-(2S)-2-[4-(4’-2-[(2S)-1-(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl-2-pyrrolidinyl]-1H-imidazol-4-yl-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl-3-methyl-1-oxo-2-butanyl]carbamate

Loading...

This page contains content from the copyrighted Wikipedia article "Daclatasvir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.